Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

NCT00656357 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: SYN117 Placebo
DRUG: SYN117 80 mg
DRUG: SYN117 160 mg
DRUG: Cocaine 10mg
DRUG: Cocaine 20mg
DRUG: Cocaine 40mg
DRUG: Saline

Sponsor

Biotie Therapies Inc.

Collaborators

[object Object]